|
|
||||||||
Eur J Cardiothorac Surg 1998;14:643-644
© 1998 Elsevier Science NL
Letter to the Editor |
Istituto di Chirurgia Toracica, Cardiovascolare e Tecnologie Biomediche, Universita degli Studi di Siena, c/o Ospedale Le Scotte, Viale Bracci 1, Siena 53100, Italy
Received 16 March 1998; received in revised form 31 August 1998; accepted 30 September 1998.
Corresponding author. Tel: +39-577-585-731; fax: +39-577-586-168; e-mail: htx@biolab.med.unisi.it
| The first 20% of the full text of this article appears below. |
Liver transplantation as an effective procedure in end-stage liver disease has created an increasing pool of patients developing systemic atherosclerosis and coronary artery disease (CAD).
A 55-year-old man with a 20-year history of type II diabetes treated with insulin and chronic bronchitis, reversible strokes, 6-year history of hypertension, esophageal varices, porto-caval anastomosis for an end-stage liver disease secondary to hepatitis B, underwent orthotopic liver transplantation in January 1994; 6 months later, the choledoc ductus was dilated and stented. Triple immunosuppressive therapy (cyclosporine, azathioprine, and prednisone) occurred between 1994 and 1996, while in January 1997 a monotherapy with Cya (3 mg/kg per day of Neoral) was started. At that time the patient presented unstable angina followed by acute
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |